Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Haematologica|April 14, 2011
Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 studySteven Le Gouill, Sophie De Guibert, Lucie Planche, et al.
Acta Haematologica|June 15, 2026
Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter studyEdmond Chiche, Caroline Fileni, Sarah Bonnet, et al.
Oncotarget|May 18, 2017
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemiaValérie Vidal, Guillaume Robert, Laure Goursaud, et al.
Haematologica|September 20, 2015
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)Laurence Simon, Aikaterini Fitsiori, Richard Lemal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2022
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal PopulationsRomain Lannes, Mehmet Samur, Aurore Perrot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, et al.
Lancet (London, England)|April 10, 2012
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 studySylvie Castaigne, Cécile Pautas, Christine Terré, et al.
Blood Advances|May 8, 2020
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study resultsClaude Gardin, Cécile Pautas, Elise Fournier, et al.
Haematologica|March 28, 2024
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationLaurent Garderet, Luuk Gras, Linda Koster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2018
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)Richard D Carvajal, Sophie Piperno-Neumann, Ellen Kapiteijn, et al.
Pageof 5